New skin lotion enters first human safety tests for common rash
NCT ID NCT07404033
Summary
This study is testing a new topical lotion called ZYG24002 for adults with mild to moderate seborrheic dermatitis, a common skin condition causing redness, scaling, and itch. The main goal is to check the safety and side effects of three different strengths of the lotion when applied once or twice daily for 28 days. Researchers will also look for early signs that the lotion might help improve the skin condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEBORRHEIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Suzhou Municipal Hospital
Suzhou, Jiangsu, 215000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.